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Introduction
We report a severe case of chronic non-bacterial osteo-
myelitis (CNO) associated with total myeloperoxidase
(MPO) deficiency.
Chronic non-bacterial osteomyelitis (CNO) is often con-
sidered an autoinflammatory disease. In pediatric literature
CNO is often referred to as chronic recurrent multifocal
ostemyelitis (CRMO). CNO is occasionally associated with
extremely rare monogenic disease but in most cases the
etiology is unknown.
MPO deficiency is characterized by low levels of
leukocyte MPO, and in some cases even total lack of the
enzyme. The condition is seldom associated with
pathology; severe Candida infection occurs in about 5% of
cases and there is a slightly increased frequency of minor
infections.
Objectives
The objectives of the case report are to describe a patient
with CNO associated to MPO deficiency, including
inflammatory markers, cytokines and phagocyte function
as well as the response to treatment.
Methods
Measurements of clinical inflammatory markers, serum
cytokines, as well as functional tests of innate
immune cells.
Results
The patient, a girl of 18 years, was healthy until the age of
10 when she developed bilateral swollen and painful
thighs. After a four-year period with numerous clinical
visits and investigations she was diagnosed with CNO. At
the time of diagnosis she suffered from severe weight loss
with a body mass index (BMI) of 10.5. Inflammatory
markers were elevated with ESR of 80 mm/h and CPR of
54 mg/ml. Radiology showed bilateral inflammation of
femur. The biopsy found unspecific inflammation. The
patient also had a total MPO deficiency that was geneti-
cally confirmed during the long period of investigation.
The patient was initially treated with NSAID without
satisfactory effect, followed by corticosteroids with only a
temporary effect. Bisphosphonates (pamidronate) and
interleukin-1 (IL-1) (anakinra) inhibition were not
effective. She responded immediately to treatment with
TNF-inhibition (adalimumab), resulting in that her
inflammatory markers normalised, her clinical symptoms
disappeared and she gained weight to a normal BMI. The
adalimumab dose and interval was titrated to 40 mg
subcutaneously every 3 weeks.
After about 3 years of treatment, a trial of withdrawal
was performed. After four weeks the patient developed
pain and general malaise, and the inflammatory markers
increased. She responded promptly to the reintroduction
of adalimumab in the same manner as she did when the
treatment was introduced.
Studies of inflammatory markers, cytokines and phago-
cyte function was performed both during the flare and
after reintroduction of adalimumab.
Conclusion
To our knowledge, this is the first time a case of CNO
associated to MPO deficiency is described. Many autoin-
flammatory diseases are IL-1 driven, which is probably not
the case in our patient as she did not respond to IL-1
blockade. She responded extremely well to TNF-blockade
both in clinical and inflammatory terms. The treatment
with TNF-blockade did not put an end the underlying
inflammatory process as her disease returned after
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withdrawal of TNF treatment. It needs to be further inves-
tigated if there is a causal relation between CNO and
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